Funding Opportunities
The NIH Small Business Program is accepting applications for SBIR & STTR funding. Learn more about these open opportunities.
Learn how to apply and what to do if you encounter systems issues.
Next receipt date: Wednesday, April. 5, 2023
Phase I grantees may be eligible for a free Technical and Business Assistance (TABA) Needs Assessment Report provided by RTI Innovation Advisors that gives a third-party, unbiased assessment of your project’s progress in four technical and business areas that are critical to success in the competitive healthcare marketplace:
- Market Needs/Competitive Advantage
- Intellectual Property/Barriers to Entry
- Business Model Profitability
- Manufacturing, Regulatory, and/or Clinical Plan
Your company is eligible to participate if your Phase I NIH SBIR or STTR (grant, contract, or Fast-Track):
- is active or was active within the past two years AND
- was not awarded TABA funding within the Phase I award budget AND
- has not already received a TABA Needs Assessment Report or NICHE Assessment for the same Phase I project.
TABA Needs Assessment Report requests are considered on a monthly basis to ensure companies receive timely guidance.
Learn more and submit a request to participate.
I-Corps at NIH is an entrepreneurship training program designed for companies that received Small Business Innovation Research or Small Business Technology Transfer funding from NIH and the Centers for Disease Control and Prevention.
During this 8-week, hands-on program, you’ll learn how to focus your business plan and get the tools to bring your treatment to the patients who need it most. And there's no cost to you – a $55,000 supplement covers program costs!
Benefits:
- Receive training from biotech sector experts
- Expand your professional network
- Build the confidence and skills to create a comprehensive business model
Applications for the next cohort are due on Wednesday, February 1, 2023, at 5:00 p.m., your local time.
The program will run from Wednesday, May 8, through Tuesday, June 27, 2023.
Learn more and apply.
Five new Research Evaluation and Commercialization Hubs (REACH) have the chance to join NIH’s nationwide proof of concept network and receive $1 million per year for four years. Hubs will provide academic innovators with the initial investment to support product validation work and access to local and NIH product development experts to help them accelerate the translation of their scientific discoveries into products that improve health and save lives.
Learn more in the funding opportunity announcement (RFA-OD-23-005). Applications are due on Thursday, February 9, 2023, with projects expected to launch in December 2023.
|
